Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles

Published by: Business Insights

Published: Jan. 1, 2010 - 221 Pages

Table of Contents

Nanotechnology in Healthcare

Executive summary

Market overview

Healthcare nanotechnology market dynamics

Nanomaterials & nanotools for the healthcare market

Healthcare nanotechnology application market

Company profiles

Chapter 1 Market overview

Summary

Introduction

Market definition

Healthcare nanotechnology business processes

Healthcare nanotechnology applications

Healthcare nanotechnology application prospects

Opportunity matrix

Challenge matrix

Patent analysis

Chapter 2 Healthcare nanotechnology market dynamics

Summary

Introduction

Regional markets

North America

Europe

Asia

RoW

Competitive landscape

R&D activities by applications

New product launches

Collaborations & agreements

Market drivers

Nanotechnology research initiatives in developing nations

Innovations are increasing

Reduced toxicity

Market inhibitors

Delay in commercialization

Stability and other issues

Need for particle evaluation

Chapter 3 Nanomaterials & nanotools for the healthcare market

Summary

Introduction

Nanomaterials

Nanocapsules

Drivers

Inhibitors

Opportunities

Nanoporous materials

Drivers

Opportunities

Quantum dots

Drivers

Inhibitors

Opportunities

Nanotubes

Drivers

Nanowires

Drivers

Inhibitors

Opportunities

Dendrimers

Drivers

Opportunities

Monoclonal antibodies

Drivers

Inhibitors

Opportunities

Nanocomposites

Fullerenes

Nanofilms

Drivers

Inhibitors

Opportunities

Nanotools

Nanoarrays

Drivers

Inhibitors

Opportunities

Nanobiochip

Drivers

Opportunities

Nanolithography arrays

Drivers

Inhibitors

Opportunities

Computer-assisted drug discovery

Nanomass spectrometry

Drivers

Inhibitors

Opportunities

Congruent Force Intermolecular Test (nanotype) C-FIT

Chapter 4 Healthcare nanotechnology application market

Summary

Introduction

Drug formulation and delivery

Formulation

Drivers

Inhibitors

Opportunities

Fluorescently encoded microparticles

Nanoparticulate formulation/systems

Fluoropolymers as material platforms for drug therapy

DNA nanoparticle technology to produce DNA drugs

Drug profiling using smart materials

Supercritical fluids and water based nanomaterials

Dendrimer nanotechnology products

Potential healthcare nanotechnology drug formulation application

Drug delivery

Drivers

Inhibitors

Opportunities

Nanoencapsulation using nano-device platform

Smart materials for encapsulation

Antimicrobial nanoencapsulation

Nanoscale cochlear drug delivery

Drug delivery using nanoparticles

Nanocrystals for drug delivery

Drug delivery coatings

Nanopores

Nanocomposites

Nanotransponders

Potential applications of healthcare nanotechnology drug delivery

Biocompatible implants and coatings

Drivers

Nanofibers fight immune response

Improvement in biocompatibility

Optimized coatings

Improvement in dental implants

Inhibitors

Improvement of implant depends upon coatings

Possibility of mass poisoning

Opportunities

Improved brain implants

Improvement in process for better coatings

Helpful in orthopedic devices

Surface modification

Device coating

Drivers

Inhibitors

Opportunities

Sol-gel coatings

Biocompatible nanocoatings

Nanoscale plasma coating

Light-activated antimicrobials

Silver nanoparticles

Hydrophobic coatings

Multifunctional coatings

Anti-fouling nanocoatings

Passive hydroxyapatite coating

Other protective coatings

Implants

Drivers

Opportunities

Potential biocompatible implants applications

Life support devices using novel biocompatible polymers

Stimulation electrodes using nanotechnology

Noninvasive killing of cancer cells using localized heat

Artificial vascular grafts

Bone graft substitutes

Regenerative medicine and wound care

Regenerative medicine/tissue engineering

Drivers

Inhibitors

Opportunities

Potential applications of regenerative medicines

Wound care

Drivers

Opportunities

Nanosilver gels

Nanogold gels

Diagnostics

Drivers

Improved bioassays

Earlier diagnosis and effective monitoring

Opportunities

Treatment of ovarian cancer

Development of immunoassays

Quantum dots applications

Nanoemulsions in multimodal molecular imaging and targeted therapeutics

Nanoparticles for biochemical applications

Magnetic nanoparticles for medical diagnostic imaging

Encapsulation of radioactive nanoparticle

Genome sequencing

Nanobiosensors

Nanoarray biochips

Silicon-based chips/sensors for pH and pressure

Micro- and nano-replication for point-of-use analytical applications

Nanocells

Redox enzymes

Other potential diagnostics applications

Smart card diagnostics

Novel microfluidic technologies

Chapter 5 Company profiles

Summary

Abraxis BioScience, Inc.

Company overview

Products and services

Company strategy

Access Pharmaceuticals, Inc.

Company overview

Products and services

Company strategy

AstraZeneca

Company overview

Products and services

Company strategy

AMAG Pharmaceuticals, Inc.

Company overview

Products and services

Company strategy

Aphios Corp.

Company overview

Products and services

Company strategy

Asklepios Biopharmaceutical Inc.

Company overview

Products and services

Company strategy

Capsulution Nanoscience AG

Company overview

Products and services

Company strategy

ConvaTec

Company overview

Products and services

Company strategy

Debiotech

Company overview

Products and services

Company strategy

Do-Coop Technologies Ltd.

Company overview

Products and services

Company strategy

Elan Corp.

Company overview

Products and services

Company strategy

Ferro Corp.

Company overview

Products and services

Company strategy

Flamel Technologies

Company overview

Products and services

Company strategy

GE Global Research

Company overview

Company strategy

GfE Medizintechnik GmbH

Company overview

Products and services

Company strategy

HemCon Medical Technologies, Inc.

Company overview

Company strategy

iCeutica Inc

Company overview

Products and services

Company strategy

Liquidia Technologies

Company overview

Company strategy

Luna Innovations Inc.

Company overview

Products and services

Company strategy

MagForce Nanotechnologies AG

Company overview

Products and services

Company strategy

Merck KGaA

Company overview

Products and services

Company strategy

MIV Therapeutics Inc

Company overview

Products and services

Company strategy

Nanomix

Company overview

Products and services

Company strategy

Nano Interface Technology, Inc

Company overview

Products and services

Company strategy

NanoCarrier Co., Ltd.

Company overview

Products and services

Company strategy

NanoDel Technologies

Company overview

Products and services

Company strategy

NanoHorizons Inc.

Company overview

Products and services

Company strategy

Nanoprobes, Inc.

Company overview

Products and services

Company strategy

Nanospectra Biosciences Inc.

Company overview

Products and services

Company strategy

Nanosphere, Inc.

Company overview

Products and services

Company strategy

Novartis AG

Company overview

Products and services

Company strategy

Pfizer

Company overview

Company strategy

PharmaSol GmbH

Company overview

Products and services

Company strategy

Pioneer Surgical Technology

Company overview

Products and services

Company strategy

pSivida

Company overview

Products and services

Company strategy

F. Hoffmann-La Roche Ltd.

Company overview

Products and services

Company strategy

Siemens Medical Solutions

Company overview

Products and services

Company strategy

Smith & Nephew

Company overview

Products and services

Company strategy

Starpharma Holdings Ltd.

Company overview

Products and services

Company strategy

T2 Biosystems Inc.

Company overview

Company strategy

Appendix

Patents

Glossary

List of Figures

Figure 1.1: Global healthcare nanotechnology market

Figure 1.2: Geographical patent share, 2003-08

Figure 1.3: Number of patents by region, 2003-09

Figure 1.4: Comparison of patent trends, 2004 vs 2009

Figure 2.5: Developmental strategies by major players, January 2007-November 2009

Figure 2.6: R&D activities by applications, Jan 2007-Nov 2009

Figure 2.7: New product launches, Jan 2007-Nov 2009

Figure 2.8: Collaborations & agreements by applications, Jan 2007-Nov2009

Figure 2.9: Relative importance of features of healthcare nanotechnology

List of Tables

Table 2.1: Global healthcare nanotech market, by geography ($m), 2007-14

Table 2.2: Mergers & acquisitions in healthcare nanotech market, 2007-09

Table 2.3: New product launches in healthcare nanotech market, 2007-09

Table 2.4: New product launches in healthcare nanotech market, 2007-09 (ctd)

Table 2.5: R&D in healthcare nanotech market, 2007-09

Table 2.6: R&D in healthcare nanotech market, 2007-09 (ctd 1)

Table 2.7: R&D in healthcare nanotech market, 2007-09 (ctd 2)

Table 2.8: R&D in healthcare nanotech market, 2007-09 (ctd 3)

Table 2.9: R&D in healthcare nanotech market, 2007-09 (ctd 4)

Table 2.10: R&D in healthcare nanotech market, 2007-09 (ctd 5)

Table 2.11: R&D in healthcare nanotech market, 2007-09 (ctd 6)

Table 2.12: Collaborations & agreements in healthcare nanotech market, 2007-09

Table 2.13: Collaborations & agreements in healthcare nanotech market, 2007-09 (ctd)

Table 4.14: Global healthcare nanotech drug formulation and delivery market, by product ($m), 2007-14

Table 4.15: Global healthcare nanotech drug formulation and delivery market, by geography ($m), 2007-14

Table 4.16: Global healthcare nanotechnology drug formulation market, by product ($m), 2007-14

Table 4.17: Global healthcare nanotech fluorescently encoded microparticles market, by geography ($m), 2007-14

Table 4.18: Global healthcare nanotech nanoparticulate formulation/systems market, by geography ($m), 2007-14

Table 4.19: Global healthcare nanotech fluoropolymers material platforms for drug therapy market, by geography ($m), 2007-14

Table 4.20: Global healthcare DNA nanoparticle technology to produce DNA drugs market, by geography ($m), 2007-14

Table 4.21: Global healthcare nanotech drug profiling using smart materials market, by geography ($m), 2007-14

Table 4.22: Global healthcare nanotech supercritical fluids and water based nanomaterials market, by geography ($m), 2007-14

Table 4.23: Global dendrimer nanotech products market by geography ($m), 2007-14

Table 4.24: Global healthcare nanotech drug delivery market by product ($m), 2007-14

Table 4.25: Global healthcare nanoencapsulation using nano-device platform market, by product ($m), 2007-14

Table 4.26: Global healthcare nanoencapsulation using nano-device platform market, by geography ($m), 2007-14

Table 4.27: Global market for smart materials encapsulating pharmaceuticals, by geography ($m), 2007-14

Table 4.28: Global healthcare nanotech antimicrobial nanoencapsulation, by geography ($m), 2007-14

Table 4.29: Global healthcare nanotech nanoscale cochlear drug delivery, by geography ($m), 2007-14

Table 4.30: Global healthcare nanotech drug delivery using nanoparticles market, by product ($m), 2007-14

Table 4.31: Global healthcare nanotech drug delivery using nanoparticles market, by geography ($m), 2007-14

Table 4.32: Global drug delivery using nanocrystals market, by geography ($m), 2007-14

Table 4.33: Global healthcare nanotech drug delivery coatings market, by geography ($m), 2007- 14

Table 4.34: Global healthcare nanopores market, by geography ($m), 2007-14

Table 4.35: Global healthcare nanocomposites market, by geography ($m), 2007-14

Table 4.36: Global healthcare nanotech nanotransponder market, by geography ($m), 2007-14

Table 4.37: Global healthcare nanotech biocompatible implants and coatings market, by products ($m), 2007-14

Table 4.38: Global healthcare nanotech biocompatible implants and coatings market, by geography ($m), 2007-14

Table 4.39: Global healthcare nanotech surface modification market, by geography ($m), 2007-14

Table 4.40: Global healthcare nanotech device coating market, by products ($m), 2007-14

Table 4.41: Global healthcare nanotech device coating market, by geography ($m), 2007-14

Table 4.42: Global healthcare nanotech implants market, by geography ($m), 2007-14

Table 4.43: Global healthcare nanotech regenerative medicine and wound care market, by products ($m), 2007-14

Table 4.44: Global healthcare nanotech regenerative medicine market, by product ($m), 2007-14

Table 4.45: Global healthcare nanotech wound care market, by products ($m), 2007-14

Table 4.46: Global healthcare nanotech diagnostics market, by products ($m), 2007-14

Table 4.47: Global healthcare nanotech diagnostics market, by geography ($m), 2007-14

Table 0.48: US patents

Table 0.49: US patents (ctd 1)

Table 0.50: US patents (ctd 2)

Table 0.51: US patents (ctd 3)

Table 0.52: US patents (ctd 4)

Table 0.53: US patents (ctd 5)

Table 0.54: US patents (ctd 6)

Table 0.55: US patents (ctd 7)

Table 0.56: US patents (ctd 8)

Table 0.57: US patents (ctd 9)

Table 0.58: US patents (ctd 10)

Table 0.59: US patents (ctd 11)

Table 0.60: US patents (ctd 12)

Table 0.61: US patents (ctd 13)

Table 0.62: US patents (ctd 14)

Table 0.63: US patents (ctd 15)

Table 0.64: US patents (ctd 16)

Table 0.65: US patents (ctd 17)

Table 0.66: US patents (ctd 18)

Table 0.67: US patents (ctd 19)

Table 0.68: Europe patents

Table 0.69: Europe patents (ctd 1)

Table 0.70: Europe patents (ctd 2)

Table 0.71: Europe patents (ctd 3)

Table 0.72: Europe patents (ctd 4)

Table 0.73: Europe patents (ctd 5)

Table 0.74: Europe patents (ctd 6)

Table 0.75: Europe patents (ctd 7)

Table 0.76: Europe patents (ctd 8)

Table 0.77: Europe patents (ctd 9)

Table 0.78: Europe patents (ctd 10)

Table 0.79: Europe patents (ctd 11)

Table 0.80: Japan patents

Table 0.81: Japan patents (ctd 1)

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.